Table 1.
Question | Answer | n | % |
---|---|---|---|
What is your specialty in the lung transplant program? | |||
Pulmonologist | 69 | 69.7 | |
Surgeon | 18 | 18.2 | |
Infectious disease physician | 7 | 7.1 | |
Intensivist | 3 | 3.0 | |
Anesthesiologist | 1 | 1.0 | |
Internist | 1 | 1.0 | |
Nurse Practitioner | 1 | 1.0 | |
No answer | 0 | 0.0 | |
Who is in charge of the antibiotic prophylaxis management? | |||
Pulmonologist | 69 | 69.7 | |
Infectious disease physician | 21 | 21.2 | |
Surgeon | 8 | 8.1 | |
Multi-disciplinary | 5 | 5.1 | |
Intensivist | 2 | 2.0 | |
Anesthesiologist | 1 | 1.0 | |
Internist | 1 | 1.0 | |
No answer | 0 | 0.0 | |
What is the main indication for lung transplant in your program? | |||
ILD | 60 | 60.6 | |
COPD | 26 | 26.3 | |
CF | 19 | 19.2 | |
Mixte | 10 | 10.1 | |
PH | 4 | 4.0 | |
No answer | 0 | 0.0 | |
Do you perform a specific induction therapy? | |||
Anti-IL2R | 56 | 56.6 | |
Steroids only | 27 | 27.3 | |
ATG | 24 | 24.2 | |
No induction | 9 | 9.1 | |
Alemtuzumab | 7 | 7.1 | |
No answer | 1 | 1.0 | |
What is the post-transplant recipient location? | |||
Cardiothoracic ICU | 56 | 56.6 | |
Medical-Surgical ICU | 19 | 19.2 | |
Surgical ICU | 13 | 13.1 | |
Transplant ICU | 7 | 7.1 | |
Medical ICU | 4 | 4.0 | |
No answer | 0 | 0.0 |
ILD Interstitial lung disease, COPD Chronic obstructive pulmonary disease, CFCYSTIC fibrosis, PH Pulmonary hypertension, Anti-IL2R Anti-IL2 receptor (basiliximab or daclizumab), ATG Anti-thymocyte globulins, ICU Intensive care unit